Polatuzumab vedotin plus rituximab and lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphoma: a cohort of a multicentre, single-arm, phase 1b/2 study
Pau Abrisqueta, Eva González‐Barca, Carlos Panizo, José María Arguiñano Pérez, Fiona Miall, Mariana Bastos‐Oreiro, Ana Triguero, Lalita Banerjee, Andrew McMillan, Erlene Seymour, Jamie Hirata, Jayson de Guzman, Sunil Sharma, Hyun Yong Jin, Lisa Musick, Catherine Diefenbach
Topics & Concepts
MedicineLenalidomideRituximabDiffuse large B-cell lymphomaInternal medicineRefractory (planetary science)LymphomaOncologyCohortPhases of clinical researchClinical trialMultiple myelomaAstrobiologyPhysicsLymphoma Diagnosis and TreatmentCAR-T cell therapy researchHER2/EGFR in Cancer Research